BroadEye: An Ophthalmology Podcast
Health & Fitness:Medicine
Jay Newman, Head of U.S. Commercial at Spark Therapeutics provides a detailed overview of gene therapy for inherited retinal disease. Jay discusses the challenges associated with gaining regulatory approval and how this approval has impacted the company and the low vision community at large.
Create your
podcast in
minutes
It is Free